| |
| |
|
| Insider
Information: |
Maduck Sean |
| Relationship: |
|
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
85,222 |
|
|
Indirect Shares
|
20,000 |
|
|
| Direct
Value |
$2,304,403 |
|
|
|
Indirect Value
|
$540,800 |
|
|
| Total
Shares |
105,222 |
|
|
| Total
Value |
$2,845,203 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -73.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Corcept Therapeutics Inc |
CORT |
|
2024-03-27 |
85,222 |
2024-03-27 |
20,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2018-05-15 |
4 |
OE |
$2.24 |
$22,400 |
D/D |
10,000 |
20,024 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2018-12-12 |
4 |
S |
$19.01 |
$1,140,366 |
D/D |
(60,000) |
20,024 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2018-12-13 |
4 |
OE |
$2.24 |
$22,400 |
D/D |
10,000 |
30,024 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2021-02-11 |
4 |
S |
$29.78 |
$101,249 |
D/D |
(3,400) |
30,024 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2021-02-16 |
4 |
S |
$28.25 |
$253,903 |
D/D |
(8,989) |
30,024 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Commercial Officer |
• – – |
2021-07-07 |
4 |
AS |
$22.19 |
$554,693 |
D/D |
(25,000) |
30,024 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2021-02-11 |
4 |
OE |
$3.29 |
$11,186 |
D/D |
3,400 |
33,424 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2021-02-16 |
4 |
OE |
$3.29 |
$29,574 |
D/D |
8,989 |
39,013 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Commercial Officer |
• – – |
2021-07-13 |
4 |
OE |
$2.24 |
$22,400 |
D/D |
10,000 |
40,024 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Commercial Officer |
• – – |
2021-08-03 |
4 |
AS |
$21.18 |
$529,420 |
D/D |
(25,000) |
40,024 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Commercial Officer |
• – – |
2021-09-01 |
4 |
AS |
$21.40 |
$534,930 |
D/D |
(25,000) |
40,024 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Commercial Officer |
• – – |
2021-10-01 |
4 |
AS |
$20.00 |
$487,375 |
D/D |
(24,363) |
40,024 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Commercial Officer |
• – – |
2021-10-05 |
4 |
AS |
$20.00 |
$12,740 |
D/D |
(637) |
40,024 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2022-07-18 |
4 |
AS |
$27.37 |
$684,250 |
D/D |
(25,000) |
40,024 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2022-08-09 |
4 |
AS |
$28.70 |
$5,740 |
D/D |
(200) |
40,024 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2022-08-12 |
4 |
OE |
$28.70 |
$711,760 |
D/D |
24,800 |
40,024 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2022-08-09 |
4 |
OE |
$1.92 |
$384 |
D/D |
200 |
40,224 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Commercial Officer |
• – – |
2021-10-05 |
4 |
OE |
$3.29 |
$2,096 |
D/D |
637 |
40,661 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2022-08-19 |
4 |
D |
$27.60 |
$11,206 |
D/D |
(406) |
54,618 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2022-09-01 |
4 |
AS |
$25.84 |
$646,000 |
D/D |
(25,000) |
54,618 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Commercial Officer |
• – – |
2021-07-07 |
4 |
OE |
$3.29 |
$82,250 |
D/D |
25,000 |
55,024 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2022-08-19 |
4 |
OE |
$2.24 |
$33,600 |
D/D |
15,000 |
55,024 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2022-09-01 |
4 |
A |
$0.00 |
$23,954 |
D/D |
1,844 |
56,462 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2022-10-03 |
4 |
AS |
$25.64 |
$641,000 |
D/D |
(25,000) |
56,462 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2022-11-10 |
4 |
AS |
$25.57 |
$639,250 |
D/D |
(25,000) |
56,462 |
0 |
% |
|
62 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
